Literature DB >> 25059665

Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro.

Mario Gonzalez-Gronow1, Cristian Farias Gomez2, Gustaaf G de Ridder3, Rupa Ray3, Salvatore V Pizzo3.   

Abstract

The glucose-regulated protein 78 (GRP78) is a plasminogen (Pg) receptor on the cell surface. In this study, we demonstrate that GRP78 also binds the tissue-type plasminogen activator (t-PA), which results in a decrease in K(m) and an increase in the V(max) for both its amidolytic activity and activation of its substrate, Pg. This results in accelerated Pg activation when GRP78, t-PA, and Pg are bound together. The increase in t-PA activity is the result of a mechanism involving a t-PA lysine-dependent binding site in the GRP78 amino acid sequence (98)LIGRTWNDPSVQQDIKFL(115). We found that GRP78 is expressed on the surface of neuroblastoma SK-N-SH cells where it is co-localized with the voltage-dependent anion channel (VDAC), which is also a t-PA-binding protein in these cells. We demonstrate that both Pg and t-PA serve as a bridge between GRP78 and VDAC bringing them together to facilitate Pg activation. t-PA induces SK-N-SH cell proliferation via binding to GRP78 on the cell surface. Furthermore, Pg binding to the COOH-terminal region of GRP78 stimulates cell proliferation via its microplasminogen domain. This study confirms previous findings from our laboratory showing that GRP78 acts as a growth factor-like receptor and that its association with t-PA, Pg, and VDAC on the cell surface may be part of a system controlling cell growth.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Brain; Brain Physiology; Cell Proliferation; GRP78; Kinetics; Neurochemistry; Pg Activation; Protein Folding; t-PA

Mesh:

Substances:

Year:  2014        PMID: 25059665      PMCID: PMC4155680          DOI: 10.1074/jbc.M114.589341

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Expression and characterization of recombinant human micro-plasminogen.

Authors:  Zhifeng Ma; Wei Lu; Sheng Wu; Junyong Chen; Ziyong Sun; Jian-Ning Liu
Journal:  Biotechnol Lett       Date:  2007-01-06       Impact factor: 2.461

2.  The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.

Authors:  Jeroen J M Hoozemans; Elise S van Haastert; Diana A T Nijholt; Annemieke J M Rozemuller; Piet Eikelenboom; Wiep Scheper
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

3.  Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism.

Authors:  Mario Gonzalez-Gronow; Miguel Cuchacovich; Rina Francos; Stephanie Cuchacovich; Maria del Pilar Fernandez; Angel Blanco; Edith V Bowers; Steven Kaczowka; Salvatore V Pizzo
Journal:  J Neuroimmunol       Date:  2010-06-23       Impact factor: 3.478

4.  Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways.

Authors:  Lu-Hua Zhang; Xiao-Liang Yang; Xiang Zhang; Jin-Xiang Cheng; Wei Zhang
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

Review 5.  GRP78 signaling hub a receptor for targeted tumor therapy.

Authors:  Masanori Sato; Virginia J Yao; Wadih Arap; Renata Pasqualini
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

6.  Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

Authors:  Elena Ortiz-Zapater; Sandra Peiró; Oriol Roda; Josep M Corominas; Susana Aguilar; Coral Ampurdanés; Francisco X Real; Pilar Navarro
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

7.  Inhibition of NF-kappaB1 and NF-kappaB2 activation in prostate cancer cells treated with antibody against the carboxyl terminal domain of GRP78: effect of p53 upregulation.

Authors:  U K Misra; S Kaczowka; S V Pizzo
Journal:  Biochem Biophys Res Commun       Date:  2010-01-25       Impact factor: 3.575

8.  A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury.

Authors:  Andre L Samson; Rachael J Borg; Be'eri Niego; Connie H Y Wong; Peter J Crack; Tang Yongqing; Robert L Medcalf
Journal:  Blood       Date:  2009-07-07       Impact factor: 22.113

Review 9.  GRP78: a multifunctional receptor on the cell surface.

Authors:  Mario Gonzalez-Gronow; Maria Angelica Selim; John Papalas; Salvatore V Pizzo
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

10.  Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis.

Authors:  Uma Kant Misra; Yvonne Mowery; Steven Kaczowka; Salvatore Vincent Pizzo
Journal:  Mol Cancer Ther       Date:  2009-05-05       Impact factor: 6.261

View more
  7 in total

Review 1.  Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies.

Authors:  Kunyu Shen; David W Johnson; David A Vesey; Michael A McGuckin; Glenda C Gobe
Journal:  Cell Stress Chaperones       Date:  2017-09-27       Impact factor: 3.667

2.  Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.

Authors:  Tino W Sanchez; Guangyu Zhang; Jitian Li; Liping Dai; Saied Mirshahidi; Nathan R Wall; Clayton Yates; Colwick Wilson; Susanne Montgomery; Jian-Ying Zhang; Carlos A Casiano
Journal:  Mol Cell Proteomics       Date:  2016-10-14       Impact factor: 5.911

3.  Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death.

Authors:  Morgane Louessard; Isabelle Bardou; Eloïse Lemarchand; Audrey M Thiebaut; Jérôme Parcq; Jérôme Leprince; Anne Terrisse; Valérie Carraro; Pierre Fafournoux; Alain Bruhat; Cyrille Orset; Denis Vivien; Carine Ali; Benoit D Roussel
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

Review 4.  Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.

Authors:  Varda Shoshan-Barmatz; Yakov Krelin; Anna Shteinfer-Kuzmine; Tasleem Arif
Journal:  Front Oncol       Date:  2017-07-31       Impact factor: 6.244

5.  Secretion of the endoplasmic reticulum stress protein, GRP78, into the BALF is increased in cigarette smokers.

Authors:  Mark O Aksoy; Victor Kim; William D Cornwell; Thomas J Rogers; Beata Kosmider; Karim Bahmed; Carlos Barrero; Salim Merali; Neena Shetty; Steven G Kelsen
Journal:  Respir Res       Date:  2017-05-02

6.  Externalized Keratin 8: A Target at the Interface of Microenvironment and Intracellular Signaling in Colorectal Cancer Cells.

Authors:  Marie Alexandra Albaret; Claudine Vermot-Desroches; Arnaud Paré; Jean-Xavier Roca-Martinez; Lucie Malet; Jad Esseily; Laetitia Gerossier; Johan Brière; Nathalie Pion; Virginie Marcel; Frédéric Catez; Geneviève De Souza; Boris Vuillermoz; Franck Doerflinger; Emilie Lavocat; Olivier Subiger; Carine Rousset; Corinne Bresson; Elodie Mandon; Anass Jawhari; Pierre Falson; Mélissa Jasmin; Yohann Coute; Hichem-Claude Mertani; Pierre Saintigny; Jean-Jacques Diaz
Journal:  Cancers (Basel)       Date:  2018-11-16       Impact factor: 6.639

Review 7.  The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.

Authors:  Alamelu G Bharadwaj; Emma Kempster; David M Waisman
Journal:  Biomolecules       Date:  2021-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.